ed@mygoodprofile.com

About Ed olimpio

This author has not yet filled in any details.
So far Ed olimpio has created 82 blog entries.

Improved Pharma announces new collaboration with Chyall Pharma

WEST LAFAYETTE, IND. (PRWEB) NOVEMBER 21, 2022 Improved Pharma is pleased to announce a new collaboration with Chyall Pharmaceutical Consulting, LLC (dba “Chyall Pharma”) enabling expansion of expertise and service offerings to the pharmaceutical industry in support of drug substance and drug product development. Chyall Pharma’s founder and President Dr. Leonard (“Len”) Chyall will serve as Read more

Improved Pharma announces new collaboration with Chyall Pharma2022-11-21T19:45:49+00:00

Unsafe Pharmaceuticals: Fake or Counterfeit

On Monday, November 14, Dr. Dale K. Purcell, President of Chemical Microscopy and consultant with Improved Pharma, will present an invited speaker “Unsafe Pharmaceuticals: Fake or Counterfeit” in the POWERHOUSE SESSION: Challenges of Counterfeit Detection in Pharmaceutical Industry.  The need to combat counterfeiting pharmaceutical drugs, the pharmaceutical packaging sector has largely implemented advanced package labeling Read more

Unsafe Pharmaceuticals: Fake or Counterfeit2022-11-07T21:20:16+00:00

Improved Pharma presenting at AAPS 2022 PHARMSCI 360 with Rapid Fire Presentation and Posters

WEST LAFAYETTE, IND. (PRWEB) SEPTEMBER 27, 2022 Improved Pharma is presenting their research on all three days of the AAPS conference. On Monday October 17th at 2:30 pm, please visit monitor #31 in forum 6. Ms. Ruba Alajlouni will present “Feasibility of Synchrotron XRD for the analysis of mixture sub-samples.” She will share results demonstrating the effective Read more

Improved Pharma presenting at AAPS 2022 PHARMSCI 360 with Rapid Fire Presentation and Posters2022-12-09T19:34:29+00:00

Improved Pharma Obtains DEA Registration for Schedules I – V

DEA registration allows Improved Pharma to support pharmaceutical development for all types of controlled substances. WEST LAFAYETTE, IND. (PRWEB) SEPTEMBER 19, 2022 Improved Pharma is pleased to announce their DEA registration for schedules I – V. The new controlled substance license enhances the wide variety of drug substances and drug products that can now be Read more

Improved Pharma Obtains DEA Registration for Schedules I – V2022-09-19T13:18:00+00:00

Ritonavir Form III: Lightning strikes twice at the same time, 137 miles apart

WEST LAFAYETTE, Ind. (PRWEB)September 13, 2022 Developing new tools and advancing pharmaceutical development is a key part of Improved Pharma’s mission. In 2021, Improved Pharma had the unique opportunity to start polymorph screening research projects in close collaboration with Varda Space Industries with the intent of advancing pharmaceutical product manufacturing. As a result, the Read more

Ritonavir Form III: Lightning strikes twice at the same time, 137 miles apart2022-09-19T13:47:51+00:00

Identification of unknown crystals in a Vicks® DayQuil Severe LiquiCap

Crystals were observed growing within a DayQuil Liquicap. This blog post describes the approach taken to isolate and identify the unknown crystals. Vicks® DayQuil™ Severe Cold & Flu provides an over the counter non-drowsy, daytime relief for common cold and flu symptoms.  DayQuil™ Severe is formulated to relieve or reduce headache, fever, sore throat, Read more

Identification of unknown crystals in a Vicks® DayQuil Severe LiquiCap2022-07-27T15:22:56+00:00

Improved Pharma at AAPS with Posters and Booth

Come see us at booth 555 and posters T1430-08-45 and T1430-08-46 Improved Pharma will be exhibiting in booth 555, conveniently located next to the 360 Center Stage. Also, Dr. Susan Bogdanowich-Knipp and Dr. Pamela Smith will be presenting posters on Tuesday afternoon from 2:30 – 3:30. The presentations will be held in Forum 8, Read more

Improved Pharma at AAPS with Posters and Booth2022-07-19T14:44:37+00:00

Improved Pharma announces new collaboration with Keystone Pharma Consulting

WEST LAFAYETTE, Ind. (PRWEB)May 11, 2022 Improved Pharma is pleased to announce a collaboration with Dr. Patricia Andres from Keystone Pharma Consulting, LLC, thus further expanding its network of pharmaceutical consultants with expertise in different areas of drug development to support its growing demand. Dr. Andres, President and founder of Keystone Pharma Consulting, LLC, Read more

Improved Pharma announces new collaboration with Keystone Pharma Consulting2022-07-27T13:36:24+00:00

Increasing the Effectiveness of Slurry Experiments to Confirm the Relative Stability of Polymorphs

Thermodynamic stability and form selection. Form selection of active pharmaceutical ingredients is regarded as an essential part of drug development. The goal of form selection is to identify the most suitable solid form for toxicological studies, drug product development, and eventually commercialization. Determining the order in which solid forms exhibit physical stability is one Read more

Increasing the Effectiveness of Slurry Experiments to Confirm the Relative Stability of Polymorphs2022-05-03T20:03:00+00:00

Improved Pharma Expands Service Offerings with Addition of VTI Corp. SGA-100 DVS for Measurement of Hygroscopicity

Improved Pharma is pleased to announce expanded capabilities with the addition of an in-house SGA-100 DVS. DVS is very useful in understanding if material is hygroscopic, and subsequently if it will lose the adsorbed water, or if material is deliquescent. In addition, DVS can aid in the identification of potential hydrates, which may be Read more

Improved Pharma Expands Service Offerings with Addition of VTI Corp. SGA-100 DVS for Measurement of Hygroscopicity2022-04-25T15:47:03+00:00
Go to Top